Modiodal Tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

modiodal tafla 100 mg

teva pharma b.v. - modafinilum inn - tafla - 100 mg

Quetiapin Medical Valley Forðatafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 200 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg

Quetiapin Medical Valley Forðatafla 400 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin medical valley forðatafla 400 mg

medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg

Quetiapine Alvogen (Quetiapin ratiopharm) Forðatafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapine alvogen (quetiapin ratiopharm) forðatafla 200 mg

alvogen ehf. - quetiapinum fúmarat - forðatafla - 200 mg

Quetiapine Alvogen (Quetiapin ratiopharm) Forðatafla 300 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapine alvogen (quetiapin ratiopharm) forðatafla 300 mg

alvogen ehf. - quetiapinum fúmarat - forðatafla - 300 mg

Quetiapine Alvogen (Quetiapin ratiopharm) Forðatafla 400 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapine alvogen (quetiapin ratiopharm) forðatafla 400 mg

alvogen ehf. - quetiapinum fúmarat - forðatafla - 400 mg

Thiamazole Uni-Pharma Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

thiamazole uni-pharma tafla 5 mg

uni-pharma kleon tsetis pharmaceutical laboratories s.a. - thiamazolum inn - tafla - 5 mg

Pombiliti Evrópusambandið - íslenska - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Elfabrio Evrópusambandið - íslenska - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Opfolda Evrópusambandið - íslenska - EMA (European Medicines Agency)

opfolda

amicus therapeutics europe limited - miglustat - glycogen geymsluskammt tegund ii - Önnur meltingarfæri og umbrotsefni - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).